| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 9533 |
| 1 | LEFLUNOMIDE | 9526 |
| 2 | METHOTREXATE SODIUM | 9487 |
| 3 | ADALIMUMAB | 9361 |
| 4 | TOCILIZUMAB | 9308 |
| 5 | PREDNISONE | 9293 |
| 6 | FOLIC ACID | 9207 |
| 7 | ALENDRONATE SODIUM | 9172 |
| 8 | METHOTREXATE | 9033 |
| 9 | ABATACEPT | 8936 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIPROLIDINE HYDROCHLORIDE | 128 | 0.6564 |
| 1 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 353 | 0.5365 |
| 2 | CORTISONE ACETATE | 6238 | 0.4990 |
| 3 | PSEUDOEPHEDRINE HCL | 5279 | 0.4822 |
| 4 | CAFFEINE CITRATE | 1007 | 0.4314 |
| 5 | DESOXIMETASONE | 8111 | 0.4208 |
| 6 | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | 106 | 0.3453 |
| 7 | TRICLOSAN | 180 | 0.3120 |
| 8 | TOFACITINIB CITRATE | 3014 | 0.2249 |
| 9 | CETIRIZINE HYDROCHLORIDE TABLETS | 7032 | 0.2241 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 10178 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 9785 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 9597 |
| 3 | Antirheumatic Agent [EPC] | 9528 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 9469 |
| 5 | Vitamin C [EPC] | 9438 |
| 6 | Vitamin B12 [EPC] | 9339 |
| 7 | Vitamin D [EPC] | 9211 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 9036 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 8936 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 869 | 1.2631 |
| 1 | Endoglycosidase [EPC] | 224 | 0.1209 |
| 2 | Interleukin-17A Antagonist [EPC] | 3994 | 0.1071 |
| 3 | Provitamin D2 Compound [EPC] | 2694 | 0.0905 |
| 4 | Antirheumatic Agent [EPC] | 9528 | 0.0901 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 722 | 0.0828 |
| 6 | Aminosalicylate [EPC] | 8207 | 0.0814 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 9469 | 0.0683 |
| 8 | Selective T Cell Costimulation Modulator [EPC] | 8936 | 0.0638 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 3399 | 0.0403 |